Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel

Combinatorial therapeutic strategies to eradicate tumors can be superior to a single therapeutic modality. Docetaxel (DT) has been approved for the treatment of local or metastasized breast cancer alone or in combination with other chemotherapeutic agents. Thymoquinone (TQ) originated from the seeds...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fadwa Odeh, Randa Naffa, Hanan Azzam, Ismail S. Mahmoud, Walhan Alshaer, Abeer Al Bawab, Said Ismail
Format: Artigo
Langue:Inglês
Publié: Elsevier 2019-11-01
Collection:Heliyon
Sujets:
Cancer research
Pharmaceutical science
Breast cancer
Docetaxel
Thymoquinone
Liposomes
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S2405844019365788
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires